Legend:
CC = Baltimore Convention Center,
H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
295 * !
Tue, 8/1/2017,
8:30 AM -
10:20 AM
CC-336
Adaptive Designs and Interim Analyses — Contributed Papers
Biopharmaceutical Section
Chair(s): John Han, Johnson & Johnson
8:35 AM
Tests and Classifications in Adaptive Designs with Applications
—
Qiusheng Chen, Florida State University ; Xufeng Niu, Florida State University
8:50 AM
A Two-Stage Design for Phase III Trials with Population Selection
—
Wen Li, Merck & Co. Inc.
9:05 AM
A Practical Bayesian Adaptive Design with Application to Cardiovascular Outcomes Trials
—
Matthew Psioda, UNC Chapel Hill ; Joseph G Ibrahim, UNC ; Mat Soukup, Center for Drug Evaluation and Research, Office of Translational Sciences, FDA
9:20 AM
Earning Regulatory Approval for a Phase II/III Design: a Case Study from Start to Finish
—
Adam Hamm, Cytel, Inc.
9:35 AM
Adaptive Designs in Phase II Basket Clinical Trials
—
Kristen Cunanan ; Alexia Iasonos, Memorial Sloan Kettering Sloan Cancer Center ; Ronglai Shen, Memorial Sloan Kettering Cancer Center ; Colin Begg, Memorial Sloan Kettering Cancer Center ; Mithat Gonen, Memorial Sloan Kettering Cancer Center
10:05 AM
A Curtailed Procedure for Comparing Treatments with Binary Response with a Control
—
Pinyuen Chen, Syracuse University ; Lifang Hsu, Le Moyne College